ABSTRACT. As the fate of glucose and lipids infused during total parenteral nutrition is not well known in infants, we assessed energy substrate oxidation in 36 patients (mean age: 5.8 f 3.6 mo) on continuous total parenteral nutrition. The infants received isocaloric feeding regimens with nonprotein energy intakes either based on glucose alone (group 1) or on glucose-lipid mixtures providing 15% (group 2), 35% (group 3), 50% (group 4), or 70% (group 5) energy as fat for at least 6 d before glucose and fat oxidation rates were measured by open-circuit indirect calorimetry. Oxidative glucose disposal reached a maximal rate of 12.6 2 1.2 mg/kg.min (17.9 f 1.7 g1kg.d) in patients with the higher glucose infusion rates. Glucose infused in excess of maximal oxidative disposal was stored, mainly as fat. The increase in glucose infusion rate was paralleled by an increase in energy expenditure amounting to 16% of the energy value of infused glucose. Net fat oxidation was only observed in group 3 (1.6 f 0.7 g/kg. d), 4 (3.4 f 0.6 g/kg.d), and 5 (3.9 f 0.4 g1kg.d) patients, with glucose infusion rates lower than 18.3 g1kg.d. However, there was no further increase in fat oxidation in group 5 as compared to group 4 patients, despite a further increase in fat intake, which only resulted in increasing fat deposition. Thus, fat infusion aiming at a significant contribution to coverage of energy expenditure requires that glucose oxidation be equal to or lower than maximal oxidative glucose disposal, hence that glucose infusion rates be lower than 18 g/kg. d. In these conditions, excessive fat deposition may be prevented by adapting fat infusion to fat oxidation capacity, which did not exceed 4 g1kg.d in our patients. (Pediatu Res 25:645-648, 1989) Abbreviations TPN, total parenteral nutrition GIR, glucose infusion rate RQ, respiratory quotient EE, energy expenditure Vo2, oxygen consumption Vco2, carbon dioxide production TPN for infants and children provides most of the energy as glucose, although it is not precisely known how much of the intravenously administered glucose is oxidized (1). Such information would be useful to determine the optimal glucose infusion rate in clinical settings, as the adverse effects of glucosebased TPN have been related, in adults, to excessive glucose infusion rates (2). Substitution of part of glucose calories with intravenous fat could reduce the undesirable effects reported with glucose-based TPN and even improve nitrogen balance (3). However, little information is available in the pediatric age about fat utilization (I), particularly regarding the possible adverse effect of simultaneous glucose infusion on the oxidation of infused fat (4).
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Therefore, we assessed glucose and fat utilization in infants during the infusion of five isocaloric TPN regimes differing in their carbohydrate to fat ratios.
MATERIALS AND METHODS
Patients. Of 40 infants on continuous TPN entered in the study, measurements were completed in 36 cases; 33 received TPN for medical gastrointestinal diseases. Enteropathogenic bacteria were isolated from the stools of eight infants with severe diarrhea, and history and clinical course were considered compatible with the diagnosis of infectious diarrhea in 18 others, although microbiologic assays were not conclusive. Five infants received TPN because of a severe diarrhea caused by allergy to cow's milk. TPN had been undertaken in these cases because either malnutrition or infection were initially present as complicating factors. Two infants received TPN because of a suspected necrotizing enterocolitis; three others received TPN after surgical procedures for congenital abnormalities of the gastrointestinal tract. Mean age (mean f SD) was 5.8 f 3.6 mo (range 2-17 mo), study wt 5 k I kg (3.6-8.2 kg), with an actual wt to expected wt for height ratio of 93 k 7% (76-1 10%). At the time of the study, all patients were on stable TPN for more than 3 wk and steadily growing (6.5 f 1.8 g1kg.d). Infants were in good clinical condition and antimicrobial therapy, when initially required, had been discontinued. Patients with infectious or metabolic diseases and inflammatory syndromes were excluded from the study. The design of the study was reviewed by the INSERM ad hoc committee. Infants entered the study after a formal, informed consent was obtained from the parents. TpN has developed into a widely used mode of nutritional TPN regimes. Nitrogen was provided as a crystalline amino support for pediatric patients, yet there are many unanswered acid solution (Primkne, Cernep, Paris, France) and nonprotein questions regarding the fate of infused substrates. For instance, energy intake was either based on glucose alone (group 1; n = 8) or on glucose-lipid (Intralipid, KB Vitrum, Stockholm, Sweden) domly assigned to one of these regimens. The characteristics of the different groups are summarized in Table 1 , and the protein and nonprotein energy intakes in Table 2 . Minerals, trace elements and vitamins were provided according to recommended intakes (1). All nutrients were concurrently delivered through a central line, by continuous infusion over 24 h. Feeding regimens were kept constant for at least 6 d before measurements were performed. Meanwhile, urine was repeatedly checked for glucose and ketone bodies (KetoDiabur test, Boehringer, Mannheim, Federal Republic of Germany) and blood glucose and electrolytes assessed every 3 d. Indirect calorimetry. Vo2 and Vc02 were continuously measured for 12 h by open-circuit indirect calorimetry, using a ventilated hood system. Oxygen concentration was assessed by a differential paramagnetic analyser (Klogor, Lannion, France) and carbon dioxide concentration by an infrared analyzer (Beckman Instruments Inc., Anaheim, CA). Gas flow was measured using a linear mass flow meter (Setaram, Lyon, France). Raw data were continuously recorded on a potentiometric chart recorder (Linseis, Selb, Federal Republic of Germany) and on floppy discs. Gas exchange was calculated as the product of gas flow times differences in oxygen and carbon dioxide concentrations between inlet and outlet of the ventilated hood. Corrections were made for effects of RQ on gas flow measurements (5). Before each measurement, the system was calibrated by nitrogen dilution tests (6) and gravimetric gas standards and regularly checked by burning butane under standard conditions. Recovery for 0 2 and CO2 were 97 t 1.8% and 98.4 + 2%, respectively, and RQ was 0.618 + 0.007 (n = 12). During the studies, urine was collected using adhesive rubber bag collectors to determine urinary nitrogen excretion.
Net substrate oxidation rates were calculated according to published methods (7, 8) , and the results were expressed as g/kg body wt/d. The following constants were used: 6.25 g of protein are oxidized to produce 1 g urea nitrogen and 966 mL 0 2 required to oxidize 1 g of protein in this way producing 773.9 mL C02. Oxygen consumed is 2019.3 mL/g of fat with RQ = 0.707 and 745.8 mL/g glucose, with a RQ = 1. When nonprotein RQ exceeded 1, fat oxidation assumed a negative value corresponding to net fat synthesis (7) . In this condition, the value for carbohydrate oxidation overestimates the conversion of glucose to C 0 2 by the amount of glucose converted to lipids (7, 8) . This amount was calculated from nonprotein O2 consumed and C 0 2 produced, according to Lillioja et al. (9) . This value was subtracted Table I . Characterisl from net glucose oxidation to obtain the oxidative glucose disposal rate. Glucose storage as glycogen and fat was calculated by subtracting oxidative glucose disposal rate from GIR. Fat deposition was obtained from fat infusion rate minus net fat oxidation rate. EE was calculated from gaseous exchange using the nonprotein RQ (7) and results expressed as kcal/kg body wt/d. Biochemical assays. Before beginning calorimetric measurements, blood samples were drawn for glucose and triglyceride determinations. Plasma insulin was measured in group 1 and group 4 patients. Blood glucose was assayed by the glucose oxidase method (lo), triglycerides by enzyme assay (1 I), and plasma insulin by RIA (12) Total urinary nitrogen was determined by the micro-Kjeldahl method (1 3).
Statistical analysis.Results are expressed as mean 5 SD. Analysis of variance and Tukey studentized range method (14) were used for comparisons between groups. Analysis of covariance was used to assess the effect of cofactors, and the equality of adjusted means was tested using the Bonferroni corrected t test. Correlations were product-moment correlations. Linear regression was applied when appropriate. All calculations were performed using the standard BMDP program (1 5).
RESULTS
There was no significant difference in height, body wt, and body wt to expected wt for height ratio between the different groups ( Table 1) . Although glucose and fat infusion rates significantly differed between groups ( p < 0.01), energy and protein intakes were comparable (Table 2 ). Plasma glucose was slightly but significantly higher in groups 1 and 2 than in group 5 ( Table  3) . None of the patients had glucosuria or ketonuria. Plasma insulin was higher in group 1 than in group 4 patients ( p < 0.01). 
* Values sharing the same symbol differ at 0.05% level. d in group 5, 4, 3, 2, and 1, respectively. EE was significantly lower in group 5 than in group 1 ( p < 0.05). The increase in EE amounted to 16% of the energy value of infused glucose. Analysis of covariance did not detect any significant effect of age, height, body wt and of body wt to expected wt for height ratio on the parameters measured in each group. 
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DISCUSSION
There was a steep increase in oxidative glucose disposal rate from group 5 to group 2 patients, as previously observed in response to increasing GIR (1 6). However, there was no further increase in oxidative glucose disposal rate in group 1 as compared 30 to group 2 patients, despite a further increase in GIR, suggesting that oxidative glucose metabolism reached a maximal rate of 17.8-17.9 g/kg.d (12.4-12.6 mg/kg min) with the higher glucose infusion rates. Determination of glucose oxidation in group 1 and 2 patients is not likely to be hampered by gluconeogenesis, as residual glucose production during high-dose glucose infusions is derived from glucose carbon cycling through the Cori cycle (17), which does not involve any net gas exchange (7) . Similarly, underestimation of net fat synthesis is not likely in group 1 patients, as fat oxidation is suppressed by high glucose infusion rates ( 18) .
A maximal oxidative glucose disposal rate has previously been demonstrated in adults, either by using indirect calorimetry (19) or "C-labeled glucose infusions (17), but has not been reported yet in infants. The maximal oxidative glucose disposal rate in group 1 and 2 patients is considerably higher than the approximately 3 mg/kg.min in adults (17, 19) , probably reflecting differences in relative metabolic rate. Indeed, we have indications from previous work (Bresson JL, Putet G, unpublished data) that maximal oxidative glucose disposal decreases with age, amounting to 8.9 + 1.4 and 5.8 + 1 mg/kg.min at age 6 and 10 y, respectively.
Glucose infusion in excess of this maximal oxidative glucose disposal resulted, in our patients, in increasing glucose storage, particularly as fat. The high cost of the glucose processing was reflected by an increase in energy expenditure with increasing GIR, as previously observed (18) . This may explain that metabolic rate in group l patients was higher than energy expenditure of normal infants with similar body height and wt (20) , whereas it was comparable in group 5 patients. Fat infusion to group 2 patients did not result in net fat oxidation but, in addition to net fat synthesis, increased fat deposition rate to the level of group 1 patients. Net fat oxidation was only achieved in group 3, 4, and 5 patients, with GIR equal to or lower than 18.3 g/kg. d. However, there was no significant 
5
-0 increase in fat oxidation in group 5 as compared to group 4 patients, despite a further increase in fat intake which only increased fat retention rate. These results suggest that fat intake may not be the major determinant of fat oxidation during continuous infusion of glucose-lipid mixtures. This is supported by the absence of any significant change in fat oxidation rate, when energy intake is increased by varying only fat intake (16) . The inverse relationship between net fat oxidation and oxidative glucose disposal, also reported in adults (9) , is in agreement with Flatt's suggestion that fat oxidation is regulated by energy needs, rather than by fat intakes (21) . The comparison of the data of Sauer et al. (22) to ours supports this hypothesis. Net fat oxidation was suppressed and net fat synthesis occurred when oxidative glucose disposal reached a maximal rate of I 1 a 0.6 g/kg. d in their newborn infants, whereas it was achieved with oxidative glucose disposal rates of 17.8 f 1.6 g1kg.d in our patients. Net fat oxidation set points thus differed in the two populations by an amount of glucose-oxidized equivalent to 25.4 kcal/kg.d, which is nearly equal to the difference in mean energy expenditure between the two grouvs of infants (49.2 f 6 and 73 t 7 kcal/kg.d, respectivel$. his suggests that during glucose-lipid mixture infusions, fat oxidation is inversely related to the amount of glucose oxidized for the coverage of energy expenditure.
Calculations differing by the assumptions made about fat oxidation constants would not significantly alter these results. The difference would be less than 5% for both net fat synthesis in group 1 and net fat oxidation in group 5, if either pure palmitate or pure intralipid fatty acids were respectively assumed to be oxidized (9, 23) . Although many of our patients were initially malnourished, at the time of the study their wt to expected wt for height ratios were within normal limits,and growth rate and metabolic rate were within the range of those of infants of comparable body height and wt (20, 24) , suggesting that these results may be relevant to TPN implementation in normally nourished infants.
Thus, glucose intakes in excess of the maximal oxidative glucose disposal rate only result in glucose storage, particularly as fat. This might account for the extensive lipid deposition reported both in liver (2) and adipose tissue (25) after glucosebased TPN. The high cost of glucose storage as fat is reflected by an increase in energy expenditure. In these conditions, fat infusion further increases fat deposition, reflecting the fat metabolism trend toward storage (26) . Fat infusion, together with high glucose infusion rates, is therefore not advisable, as it may result in very high fat retention rates and possibly fat overloading. Fat infusion aimed at a significant coverage of energy expenditure requires that glucose oxidation rates be lower than the maximal oxidative glucose disposal, hence that GIR be lower than 18 g/kg. d. In these conditions, energy expenditure is lower, and excessive fat deposition may be prevented by adapting fat infusion rate to fat oxidation capacity, which did not exceed 4 g/kg.d in our patients.
